SEC Filing Update: #SABS SAB Biotherapeutics, Inc. : $3.80

Sector: Healthcare | YTD: 🔼+ 1.33% The SEC disclosed Today (12-AUG-2026) that Adage Capital Management, L.P. has Newly bought 6,405,553 #SABS shares Ownership: 8.38% * Estimated Investment Value: $24.08M https://www.thinksabio.com/reports/isr/SABS Institutional ownership in #SABS has been steadily rising over the past 4 quarters in Shares: Q2 2025: 1.92M Q3 2025: 28.02M Q4 2025: 36.34M Q1 2026: 69.19M 📌 Institutional activity in the last 30 days for #SABS: • RA CAPITAL MANAGEMENT – Increased holdings by 5,208,352 shares (10-AUG-2026)